COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,935 Articles (22,057 medRxiv, 7,878 bioRxiv)

Most recent first Previous |  Page 2692: Articles 26911-26920  | Next

Safe Blues: A Method for Estimation and Control in the Fight Against COVID-19
Abhijit Dandekar, R., Henderson, S. G., Jansen, M., Moka, S., Nazarathy, Y., Rackauckas, C., Taylor, P. G., Vuorinen, A.
10.1101/2020.05.04.20090258 — Posted: 2020-05-08
Assessing the impact of non-pharmaceutical interventions on SARS-CoV-2 transmission in Switzerland
Lemaitre, J. C., Perez-Saez, J., Azman, A., Rinaldo, A., Fellay, J.
10.1101/2020.05.04.20090639 — Posted: 2020-05-08 Discussion: Offsite
Segmentation and shielding of the most vulnerable members of the population as elements of an exit strategy from COVID-19 lockdown
van Bunnik, B. A. D., Morgan, A. L. K., Bessell, P., Calder-Gerver, G., Zhang, F., Haynes, S., Ashworth, J., Zhao, S., Cave, N. R., Perry, M. R., Lepper, H. C., Lu, L., Kellam, P., Sheikh, A., Medley, G. F., Woolhouse, M. E. J.
10.1101/2020.05.04.20090597 — Posted: 2020-05-08
Collider bias undermines our understanding of COVID-19 disease risk and severity
Griffith, G., Morris, T. T., Tudball, M., Herbert, A., Mancano, G., Pike, L., Sharp, G. C., Palmer, T. M., Davey Smith, G., Tilling, K., Zuccolo, L., Davies, N. M., Hemani, G.
10.1101/2020.05.04.20090506 — Posted: 2020-05-08 Discussion: Onsite
Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio for predicting clinical outcomes in COVID-19
Huang, S., Huang, M., Li, X., Zhang, T., Lu, H.
10.1101/2020.05.04.20090431 — Posted: 2020-05-08
A mathematical assessment of the efficiency of quarantining and contact tracing in curbing the COVID-19 epidemic
Lambert, A.
10.1101/2020.05.04.20091009 — Posted: 2020-05-08
Characteristics of patients presenting, and not presenting, to the emergency department during the early days of COVID-19
Westgard, B. C., Morgan, M. W., Vazquez-Benitez, G., Erickson, L. O., Zwank, M. D.
10.1101/2020.05.05.20090795 — Posted: 2020-05-08
Impact of hospitalised patients with COVID-19 taking Renin-Angiotensin-Aldosterone System inhibitors: a systematic review and meta-analysis
Baral, R., White, M., Vassiliou, V. S.
10.1101/2020.05.03.20089375 — Posted: 2020-05-08
Protocol for a systematic review of qualitative and quantitative effects of cardiovascular disease risk communication using heart age concepts
Bonner, C., Cornell, S., Batcup, C., Fajardo, M., Doust, J., McGeechan, K., Trevena, L.
10.1101/2020.05.03.20089938 — Posted: 2020-05-08
Reduced mortality and shorten ICU stay in SARS-COV-2 pneumonia: a low PEEP strategy
Ceruti, S., Roncador, M., Gie, O., Bona, G., Iattoni, M., Biggiogero, M., Maida, P. A., COVID-19 Clinical Management Team, , Garzoni, C., Mauri, R.
10.1101/2020.05.03.20089318 — Posted: 2020-05-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).